rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Sean Wuxiong Cao

Chief Bus. Development Officer

Company insider

Files Form 4 as: Chief Bus. Development Officer, NovaBridge Biosciences.

In numbers

Trades disclosed
16
Buys
0
Sells
2
Bought
$0
Sold
$245K
Companies
1
Companies where not an officer
0
First trade
14 May 2026
Last trade
9 Sep 2026
Last filed
11 Sep 2026

Companies traded

Where they are an officer
NBP NovaBridge BiosciencesDirector, Officer · Biotechnology · last 9 Sep 20260 buys · 2 sells

Activity over time

1 May – 1 Oct
10May 26Jun 26Aug 26Sep 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
9 Sep 2026filed 11 Sep 2026NBP NovaBridge BiosciencesBiotechnologySEC FORM 4 Sold$80K107,978 at $0.74filing
9 Sep 2026filed 11 Sep 2026NBP NovaBridge BiosciencesBiotechnologySEC FORM 4 Sold$80K107,978 at $0.74filing
3 Sep 2026filed 8 Sep 2026NBP NovaBridge BiosciencesBiotechnologySEC FORM 4 Code M—235,136filing
3 Sep 2026filed 8 Sep 2026NBP NovaBridge BiosciencesBiotechnologySEC FORM 4 Code M—104,236filing
3 Sep 2026filed 8 Sep 2026NBP NovaBridge Biosciencesoption or derivative · BiotechnologySEC FORM 4 Code M—102,233 at $0.00filing
3 Sep 2026filed 8 Sep 2026NBP NovaBridge Biosciencesoption or derivative · BiotechnologySEC FORM 4 Code M—102,233 at $0.00filing
3 Sep 2026filed 8 Sep 2026NBP NovaBridge Biosciencesoption or derivative · BiotechnologySEC FORM 4 Code M—45,320 at $0.00filing
3 Sep 2026filed 8 Sep 2026NBP NovaBridge Biosciencesoption or derivative · BiotechnologySEC FORM 4 Code M—45,320 at $0.00filing
3 Sep 2026filed 8 Sep 2026NBP NovaBridge BiosciencesBiotechnologySEC FORM 4 Code M—235,136filing
3 Sep 2026filed 8 Sep 2026NBP NovaBridge BiosciencesBiotechnologySEC FORM 4 Code M—104,236filing
22 Jun 2026filed 24 Jun 2026NBP NovaBridge Biosciencesoption or derivative · BiotechnologySEC FORM 4 Code A—181,280 at $0.00filing
22 Jun 2026filed 24 Jun 2026NBP NovaBridge Biosciencesoption or derivative · BiotechnologySEC FORM 4 Code A—181,290 at $0.00filing
22 Jun 2026filed 24 Jun 2026NBP NovaBridge Biosciencesoption or derivative · BiotechnologySEC FORM 4 Code A—181,280 at $0.00filing
22 Jun 2026filed 24 Jun 2026NBP NovaBridge Biosciencesoption or derivative · BiotechnologySEC FORM 4 Code A—181,290 at $0.00filing
14 May 2026filed 18 May 2026NBP NovaBridge BiosciencesBiotechnologySEC FORM 4 Sold$43K21,399 at $1.99filing
14 May 2026filed 18 May 2026NBP NovaBridge BiosciencesBiotechnologySEC FORM 4 Sold$43K21,399 at $1.99filing

News

I-Mab (NASDAQ:NBP) Insider Sean Wuxiong Cao Sells 107,978 Sharesdailypolitical.com · 12 Sep 2026

1 headline in the last 90 days name Sean Wuxiong Cao; 0 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.

Sectors

Health Care2

Buys in green, sells in red, by the company’s sector.

Related people

Ian Ying WooDirector · Director at NovaBridge Biosciences, filing Form 4 there in the last year
Phillip Andrew DennisChief Medical Officer · Chief Medical Officer at NovaBridge Biosciences, filing Form 4 there in the last year
Cong Claire XuEVP, Clinical Development · EVP, Clinical Development at NovaBridge Biosciences, filing Form 4 there in the last year
Robert A. LenzDirector · Director at NovaBridge Biosciences, filing Form 4 there in the last year
Mark Arnold HaglerChief Commercial Officer · Chief Commercial Officer at NovaBridge Biosciences, filing Form 4 there in the last year